GoodRx vs Zealthy

Zealthy has an open FDA warning letter dated September 9, 2025. GoodRx has none. No price lines up like for like: GoodRx and Zealthy publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

GoodRx / Zealthy

GoodRx logo

GoodRx

7.8/10

Zealthy logo

Zealthy

5.6/10

FDA warning letters
None on record
Pharmacy
Brand-name only; no compounding
None named in our record
Lowest standing price
$149/moFoundayo (orforglipron) pill
$286/moCompounded semaglutide injection, medication only, membership extra
States
48 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither GoodRx nor Zealthy pays us. Links to them earn nothing. Scores: GoodRx 7.8, Zealthy 5.6. How we are paid

What the record shows

  1. 01

    Zealthy has an open FDA warning letter dated September 9, 2025. GoodRx has none.

  2. 02

    Zealthy names no compounding pharmacy in our record. GoodRx sells brand-name medication only.

  3. 03

    No price lines up like for like: GoodRx and Zealthy publish prices for different products.

  4. 04

    Only GoodRx lists a price for brand-name tirzepatide pen and Foundayo (orforglipron) pill. Only Zealthy lists a price for compounded semaglutide injection and compounded tirzepatide injection.

  5. 05

    Zealthy covers two states GoodRx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

GoodRx

Zealthy

Compounded semaglutide injection
Not sold or not priced

$286/mo

medication only, membership extra; not compared

Compounded tirzepatide injection
Not sold or not priced

$351/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen

$299/mo

$3,588 a year

Not sold or not priced
Foundayo (orforglipron) pill

$149/mo

$1,788 a year

Not sold or not priced
Price includes
Not stated
Clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
Monthly membership that renews automatically; quarterly, semi-annual and annual memberships are also sold
Refunds
Services and medication are generally non-refundable
Medication, consultation and membership charges are non-refundable

Read off each seller’s own pages. GoodRx: October 30, 2026. Zealthy: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for GoodRx

7.8/10
  • No FDA warning letter on record
  • Sells brand-name tirzepatide pen and Foundayo (orforglipron) pill, which Zealthy does not price

The case for Zealthy

5.6/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which GoodRx does not price
  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
  • Lowest price covers the medication only, with a separate membership on top

Scores

GoodRx 7.8 · Zealthy 5.6 out of 10. Six weighted parts.

Value25%

8.7A
vs
B
3.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

5.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
2.0

Accessibility10%

9.7A
vs
B
10.0

Support10%

5.0A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

GoodRx vs Zealthy: questions

Zealthy has an open FDA warning letter dated September 9, 2025. GoodRx has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Zealthy names no compounding pharmacy in our record. GoodRx sells brand-name medication only.
No price lines up like for like: GoodRx and Zealthy publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
GoodRx states you can cancel at any time; refunds: services and medication are generally non-refundable. Zealthy states you can cancel at any time; refunds: medication, consultation and membership charges are non-refundable.
Neither GoodRx nor Zealthy pays us. Links to them earn nothing. Scores: GoodRx 7.8, Zealthy 5.6.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks